ID   FGF2_CAVPO              Reviewed;         170 AA.
AC   Q60487;
DT   24-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 2.
DT   07-APR-2021, entry version 119.
DE   RecName: Full=Fibroblast growth factor 2;
DE            Short=FGF-2;
DE   AltName: Full=Basic fibroblast growth factor;
DE            Short=bFGF;
DE   AltName: Full=Heparin-binding growth factor 2;
DE            Short=HBGF-2;
DE   AltName: Full=Prostatic growth factor;
DE   Flags: Fragments;
GN   Name=FGF2;
OS   Cavia porcellus (Guinea pig).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Hystricomorpha; Caviidae;
OC   Cavia.
OX   NCBI_TaxID=10141;
RN   [1]
RP   PROTEIN SEQUENCE OF N-TERMINUS, PARTIAL PROTEIN SEQUENCE, AND ALTERNATIVE
RP   INITIATION.
RX   PubMed=2730645; DOI=10.1016/s0006-291x(89)80140-8;
RA   Sommer A., Moscatelli D., Rifkin D.B.;
RT   "An amino-terminally extended and post-translationally modified form of a
RT   25kD basic fibroblast growth factor.";
RL   Biochem. Biophys. Res. Commun. 160:1267-1274(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 53-170.
RC   TISSUE=Prostate;
RA   Ricciardelli C.;
RL   Submitted (JAN-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   PARTIAL PROTEIN SEQUENCE, AND METHYLATION AT ARG-4; ARG-6 AND ARG-8.
RX   PubMed=1713785; DOI=10.1091/mbc.2.2.87;
RA   Burgess W.H., Bizik J., Mehlman T., Quarto N., Rifkin D.B.;
RT   "Direct evidence for methylation of arginine residues in high molecular
RT   weight forms of basic fibroblast growth factor.";
RL   Cell Regul. 2:87-93(1991).
RN   [4]
RP   CHARACTERIZATION.
RC   TISSUE=Brain;
RX   PubMed=3475702; DOI=10.1073/pnas.84.16.5778;
RA   Moscatelli D., Joseph-Silverstein J., Manejias R., Rifkin D.B.;
RT   "Mr 25,000 heparin-binding protein from guinea pig brain is a high
RT   molecular weight form of basic fibroblast growth factor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:5778-5782(1987).
CC   -!- FUNCTION: Acts as a ligand for FGFR1, FGFR2, FGFR3 and FGFR4 (By
CC       similarity). Also acts as an integrin ligand which is required for FGF2
CC       signaling (By similarity). Binds to integrin ITGAV:ITGB3 (By
CC       similarity). Plays an important role in the regulation of cell
CC       survival, cell division, cell differentiation and cell migration (By
CC       similarity). Functions as a potent mitogen in vitro (By similarity).
CC       Can induce angiogenesis (By similarity). Mediates phosphorylation of
CC       ERK1/2 and thereby promotes retinal lens fiber differentiation (By
CC       similarity). {ECO:0000250|UniProtKB:P09038}.
CC   -!- SUBUNIT: Monomer. Homodimer. Interacts with FGFR1, FGFR2, FGFR3 and
CC       FGFR4. Affinity between fibroblast growth factors (FGFs) and their
CC       receptors is increased by heparan sulfate glycosaminoglycans that
CC       function as coreceptors. Interacts with CSPG4, FGFBP1 and TEC. Found in
CC       a complex with FGFBP1, FGF1 and FGF2. Interacts with FGFBP3. Interacts
CC       with integrin ITGAV:ITGB3; the interaction is required for FGF2
CC       signaling. Interacts with SNORC (via the extracellular domain).
CC       Interacts with glypican GPC3. {ECO:0000250|UniProtKB:P09038,
CC       ECO:0000250|UniProtKB:P13109, ECO:0000250|UniProtKB:P15655}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:P09038}. Nucleus
CC       {ECO:0000250|UniProtKB:P09038}. Note=Exported from cells by an
CC       endoplasmic reticulum (ER)/Golgi-independent mechanism (By similarity).
CC       Unconventional secretion of FGF2 occurs by direct translocation across
CC       the plasma membrane (By similarity). Binding of exogenous FGF2 to FGFR
CC       facilitates endocytosis followed by translocation of FGF2 across
CC       endosomal membrane into the cytosol (By similarity). Nuclear import
CC       from the cytosol requires the classical nuclear import machinery,
CC       involving proteins KPNA1 and KPNB1, as well as CEP57 (By similarity).
CC       {ECO:0000250|UniProtKB:P09038}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=1; Synonyms=25 kDa;
CC         IsoId=Q60487-1; Sequence=Displayed;
CC       Name=2; Synonyms=18 kDa;
CC         IsoId=Q60487-2; Sequence=VSP_018726;
CC   -!- PTM: The N-terminus of isoform 2 is blocked. {ECO:0000305}.
CC   -!- PTM: Phosphorylation at Tyr-97 regulates FGF2 unconventional secretion.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the heparin-binding growth factors family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA85394.1; Type=Frameshift; Note=The correction of the frameshifts allows to extend the similarity to the human sequence and is based on partial amino-acid sequencing.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L75974; AAA85394.1; ALT_FRAME; mRNA.
DR   SMR; Q60487; -.
DR   STRING; 10141.ENSCPOP00000004847; -.
DR   iPTMnet; Q60487; -.
DR   PRIDE; Q60487; -.
DR   eggNOG; KOG3885; Eukaryota.
DR   InParanoid; Q60487; -.
DR   OMA; NDPHIKL; -.
DR   Proteomes; UP000005447; Unassembled WGS sequence.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005104; F:fibroblast growth factor receptor binding; IEA:InterPro.
DR   GO; GO:0008083; F:growth factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0008201; F:heparin binding; IEA:UniProtKB-KW.
DR   GO; GO:0005178; F:integrin binding; ISS:UniProtKB.
DR   GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; ISS:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; IEA:InterPro.
DR   GO; GO:0060548; P:negative regulation of cell death; ISS:UniProtKB.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; ISS:UniProtKB.
DR   GO; GO:0043536; P:positive regulation of blood vessel endothelial cell migration; ISS:UniProtKB.
DR   GO; GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW.
DR   GO; GO:0090050; P:positive regulation of cell migration involved in sprouting angiogenesis; ISS:UniProtKB.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:UniProtKB.
DR   GO; GO:1902748; P:positive regulation of lens fiber cell differentiation; ISS:UniProtKB.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:1903672; P:positive regulation of sprouting angiogenesis; ISS:UniProtKB.
DR   CDD; cd00058; FGF; 1.
DR   InterPro; IPR028223; FGF2.
DR   InterPro; IPR002209; Fibroblast_GF_fam.
DR   InterPro; IPR008996; IL1/FGF.
DR   PANTHER; PTHR11486; PTHR11486; 1.
DR   PANTHER; PTHR11486:SF83; PTHR11486:SF83; 1.
DR   Pfam; PF00167; FGF; 1.
DR   PRINTS; PR00263; HBGFFGF.
DR   SMART; SM00442; FGF; 1.
DR   SUPFAM; SSF50353; SSF50353; 1.
DR   PROSITE; PS00247; HBGF_FGF; 1.
PE   1: Evidence at protein level;
KW   Alternative initiation; Angiogenesis; Developmental protein;
KW   Differentiation; Direct protein sequencing; Growth factor; Heparin-binding;
KW   Isopeptide bond; Methylation; Mitogen; Nucleus; Phosphoprotein;
KW   Reference proteome; Secreted; Ubl conjugation.
FT   CHAIN           <1..170
FT                   /note="Fibroblast growth factor 2"
FT                   /id="PRO_0000008930"
FT   REGION          143..159
FT                   /note="Heparin-binding"
FT                   /evidence="ECO:0000250"
FT   BINDING         51
FT                   /note="Heparin"
FT                   /evidence="ECO:0000250"
FT   SITE            143
FT                   /note="Important for interaction with integrin"
FT                   /evidence="ECO:0000250|UniProtKB:P09038"
FT   SITE            144
FT                   /note="Important for interaction with integrin"
FT                   /evidence="ECO:0000250|UniProtKB:P09038"
FT   SITE            149
FT                   /note="Important for interaction with integrin"
FT                   /evidence="ECO:0000250|UniProtKB:P09038"
FT   MOD_RES         4
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000269|PubMed:1713785"
FT   MOD_RES         4
FT                   /note="Symmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000269|PubMed:1713785"
FT   MOD_RES         6
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000269|PubMed:1713785"
FT   MOD_RES         6
FT                   /note="Symmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000269|PubMed:1713785"
FT   MOD_RES         8
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000269|PubMed:1713785"
FT   MOD_RES         8
FT                   /note="Symmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000269|PubMed:1713785"
FT   MOD_RES         97
FT                   /note="Phosphotyrosine; by TEC"
FT                   /evidence="ECO:0000250|UniProtKB:P09038"
FT   CROSSLNK        110
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1)"
FT                   /evidence="ECO:0000250|UniProtKB:P09038"
FT   VAR_SEQ         <1..21
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_018726"
FT   NON_CONS        15..16
FT                   /evidence="ECO:0000305"
FT   NON_CONS        50..51
FT                   /evidence="ECO:0000305"
FT   NON_TER         1
SQ   SEQUENCE   170 AA;  18354 MW;  F36BDBC736E5FEBE CRC64;
     VGGRGRGRGT AAAARREPGG AMAAGSITTL PALPEGGDGG AFAPGHFKDP NGGFFLRIHP
     DGRVDGVREK TDPHIKLQLQ AEDRGVVSIK GVCANRYLAM KEDGRLLASK CVTDECFFFE
     RLESNNYNTY RSRKYSSWYV ALKRTGQYKL GSKTGPGQKA ILFLPMSAKS
//
